ID   NEK4_HUMAN              Reviewed;         841 AA.
AC   P51957; A5YM70; B2R633; B7Z200; Q6P576;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Serine/threonine-protein kinase Nek4;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q9Z1J2};
DE   AltName: Full=Never in mitosis A-related kinase 4;
DE            Short=NimA-related protein kinase 4;
DE   AltName: Full=Serine/threonine-protein kinase 2;
DE   AltName: Full=Serine/threonine-protein kinase NRK2;
GN   Name=NEK4; Synonyms=STK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ALA-225, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Mammary gland;
RX   PubMed=8208544;
RA   Levedakou E.N., He M., Baptist E.W., Craven R.J., Cance W.G.,
RA   Welcsh P.L., Simmons A., Naylor S.L., Leach R.J., Lewis T.B.,
RA   Bowcock A., Liu E.T.;
RT   "Two novel human serine/threonine kinases with homologies to the cell
RT   cycle regulating Xenopus MO15, and NIMA kinases: cloning and
RT   characterization of their expression pattern.";
RL   Oncogene 9:1977-1988(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-225.
RA   Schupp I.;
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Amygdala, and Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ALA-225.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   INTERACTION WITH RPGRIP1 AND RPGRIP1L, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=21685204; DOI=10.1093/hmg/ddr280;
RA   Coene K.L., Mans D.A., Boldt K., Gloeckner C.J., van Reeuwijk J.,
RA   Bolat E., Roosing S., Letteboer S.J., Peters T.A., Cremers F.P.,
RA   Ueffing M., Roepman R.;
RT   "The ciliopathy-associated protein homologs RPGRIP1 and RPGRIP1L are
RT   linked to cilium integrity through interaction with Nek4
RT   serine/threonine kinase.";
RL   Hum. Mol. Genet. 20:3592-3605(2011).
RN   [9]
RP   FUNCTION.
RX   PubMed=22851694; DOI=10.1128/MCB.00436-12;
RA   Nguyen C.L., Possemato R., Bauerlein E.L., Xie A., Scully R.,
RA   Hahn W.C.;
RT   "Nek4 regulates entry into replicative senescence and the response to
RT   DNA damage in human fibroblasts.";
RL   Mol. Cell. Biol. 32:3963-3977(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340; SER-343; SER-461
RP   AND SER-563, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-622, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-225; GLY-239; LEU-250; ILE-357;
RP   GLU-456; LEU-567 AND LYS-777.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein kinase that seems to act exclusively upon
CC       threonine residues (By similarity). Required for normal entry into
CC       proliferative arrest after a limited number of cell divisions,
CC       also called replicative senescence. Required for normal cell cycle
CC       arrest in response to double-stranded DNA damage.
CC       {ECO:0000250|UniProtKB:Q9Z1J2, ECO:0000269|PubMed:22851694}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000250|UniProtKB:Q9Z1J2}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q9Z1J2};
CC   -!- SUBUNIT: Interacts with RPGRIP1 and RPGRIP1L.
CC       {ECO:0000269|PubMed:21685204}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium
CC       {ECO:0000269|PubMed:21685204}. Cytoplasm
CC       {ECO:0000269|PubMed:21685204}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P51957-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51957-2; Sequence=VSP_037123, VSP_037124;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P51957-3; Sequence=VSP_043334;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highest expression in adult heart, followed by
CC       pancreas, skeletal muscle, brain, testis, retina, liver, kidney,
CC       lung and placenta. Present in most primary carcinomas.
CC       {ECO:0000269|PubMed:21685204, ECO:0000269|PubMed:8208544}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr
CC       protein kinase family. NIMA subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L20321; AAA36658.1; -; mRNA.
DR   EMBL; EF560744; ABQ59054.1; -; mRNA.
DR   EMBL; AK294165; BAH11686.1; -; mRNA.
DR   EMBL; AK312420; BAG35330.1; -; mRNA.
DR   EMBL; AC006254; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104446; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC063044; AAH63044.1; -; mRNA.
DR   CCDS; CCDS2863.1; -. [P51957-1]
DR   CCDS; CCDS54593.1; -. [P51957-3]
DR   PIR; I78885; I78885.
DR   RefSeq; NP_001180462.1; NM_001193533.2. [P51957-3]
DR   RefSeq; NP_001335342.1; NM_001348413.1. [P51957-2]
DR   RefSeq; NP_003148.2; NM_003157.5. [P51957-1]
DR   UniGene; Hs.631921; -.
DR   ProteinModelPortal; P51957; -.
DR   SMR; P51957; -.
DR   BioGrid; 112663; 27.
DR   IntAct; P51957; 10.
DR   STRING; 9606.ENSP00000233027; -.
DR   BindingDB; P51957; -.
DR   ChEMBL; CHEMBL5819; -.
DR   GuidetoPHARMACOLOGY; 2119; -.
DR   iPTMnet; P51957; -.
DR   PhosphoSitePlus; P51957; -.
DR   BioMuta; NEK4; -.
DR   DMDM; 229462924; -.
DR   EPD; P51957; -.
DR   MaxQB; P51957; -.
DR   PaxDb; P51957; -.
DR   PeptideAtlas; P51957; -.
DR   PRIDE; P51957; -.
DR   Ensembl; ENST00000233027; ENSP00000233027; ENSG00000114904. [P51957-1]
DR   Ensembl; ENST00000383721; ENSP00000373227; ENSG00000114904. [P51957-2]
DR   Ensembl; ENST00000535191; ENSP00000437703; ENSG00000114904. [P51957-3]
DR   GeneID; 6787; -.
DR   KEGG; hsa:6787; -.
DR   UCSC; uc003dfq.5; human. [P51957-1]
DR   CTD; 6787; -.
DR   DisGeNET; 6787; -.
DR   GeneCards; NEK4; -.
DR   H-InvDB; HIX0030800; -.
DR   HGNC; HGNC:11399; NEK4.
DR   HPA; HPA015750; -.
DR   MIM; 601959; gene.
DR   neXtProt; NX_P51957; -.
DR   OpenTargets; ENSG00000114904; -.
DR   PharmGKB; PA31548; -.
DR   eggNOG; KOG0589; Eukaryota.
DR   eggNOG; ENOG410Y7JF; LUCA.
DR   GeneTree; ENSGT00760000118997; -.
DR   HOGENOM; HOG000294177; -.
DR   HOVERGEN; HBG031740; -.
DR   InParanoid; P51957; -.
DR   KO; K08857; -.
DR   OMA; SELESCW; -.
DR   OrthoDB; EOG091G0GU4; -.
DR   PhylomeDB; P51957; -.
DR   TreeFam; TF106472; -.
DR   SignaLink; P51957; -.
DR   ChiTaRS; NEK4; human.
DR   GenomeRNAi; 6787; -.
DR   PMAP-CutDB; P51957; -.
DR   PRO; PR:P51957; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114904; -.
DR   CleanEx; HS_NEK4; -.
DR   ExpressionAtlas; P51957; baseline and differential.
DR   Genevisible; P51957; HS.
DR   GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; ISS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:CACAO.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:2000772; P:regulation of cellular senescence; IMP:UniProtKB.
DR   GO; GO:1900062; P:regulation of replicative cell aging; IMP:UniProtKB.
DR   GO; GO:2001020; P:regulation of response to DNA damage stimulus; IMP:CACAO.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Cell projection; Complete proteome; Cytoplasm; Kinase; Magnesium;
KW   Metal-binding; Methylation; Mitosis; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    841       Serine/threonine-protein kinase Nek4.
FT                                /FTId=PRO_0000086425.
FT   DOMAIN        6    261       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      12     20       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    131    131       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      35     35       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     165    165       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     340    340       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     343    343       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     461    461       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     563    563       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     622    622       N6-methyllysine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     723    723       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1J2}.
FT   VAR_SEQ      32    120       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043334.
FT   VAR_SEQ     457    502       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037123.
FT   VAR_SEQ     813    841       RLREHMGEKYTTYSVKARQLKFFEENMNF -> SVSLTVSR
FT                                CLCYRIF (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037124.
FT   VARIANT     225    225       P -> A (in dbSNP:rs1029871).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:8208544,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_040915.
FT   VARIANT     239    239       R -> G (in dbSNP:rs35778416).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040916.
FT   VARIANT     250    250       P -> L (in dbSNP:rs56408749).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040917.
FT   VARIANT     357    357       T -> I (in dbSNP:rs2230537).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040918.
FT   VARIANT     456    456       Q -> E (in dbSNP:rs56019351).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040919.
FT   VARIANT     567    567       F -> L (in dbSNP:rs34986855).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040920.
FT   VARIANT     777    777       R -> K (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040921.
FT   CONFLICT     63     63       P -> L (in Ref. 3; BAG35330).
FT                                {ECO:0000305}.
FT   CONFLICT     64     64       N -> D (in Ref. 2; ABQ59054).
FT                                {ECO:0000305}.
FT   CONFLICT    333    333       R -> K (in Ref. 3; BAG35330).
FT                                {ECO:0000305}.
SQ   SEQUENCE   841 AA;  94597 MW;  43E8F11BA4007263 CRC64;
     MPLAAYCYLR VVGKGSYGEV TLVKHRRDGK QYVIKKLNLR NASSRERRAA EQEAQLLSQL
     KHPNIVTYKE SWEGGDGLLY IVMGFCEGGD LYRKLKEQKG QLLPENQVVE WFVQIAMALQ
     YLHEKHILHR DLKTQNVFLT RTNIIKVGDL GIARVLENHC DMASTLIGTP YYMSPELFSN
     KPYNYKSDVW ALGCCVYEMA TLKHAFNAKD MNSLVYRIIE GKLPPMPRDY SPELAELIRT
     MLSKRPEERP SVRSILRQPY IKRQISFFLE ATKIKTSKNN IKNGDSQSKP FATVVSGEAE
     SNHEVIHPQP LSSEGSQTYI MGEGKCLSQE KPRASGLLKS PASLKAHTCK QDLSNTTELA
     TISSVNIDIL PAKGRDSVSD GFVQENQPRY LDASNELGGI CSISQVEEEM LQDNTKSSAQ
     PENLIPMWSS DIVTGEKNEP VKPLQPLIKE QKPKDQSLAL SPKLECSGTI LAHSNLRLLG
     SSDSPASASR VAGITGVCHH AQDQVAGECI IEKQGRIHPD LQPHNSGSEP SLSRQRRQKR
     REQTEHRGEK RQVRRDLFAF QESPPRFLPS HPIVGKVDVT STQKEAENQR RVVTGSVSSS
     RSSEMSSSKD RPLSARERRR LKQSQEEMSS SGPSVRKASL SVAGPGKPQE EDQPLPARRL
     SSDCSVTQER KQIHCLSEDE LSSSTSSTDK SDGDYGEGKG QTNEINALVQ LMTQTLKLDS
     KESCEDVPVA NPVSEFKLHR KYRDTLILHG KVAEEAEEIH FKELPSAIMP GSEKIRRLVE
     VLRTDVIRGL GVQLLEQVYD LLEEEDEFDR EVRLREHMGE KYTTYSVKAR QLKFFEENMN
     F
//
